⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2085606 | 0.63 | — | — | |
| SCHEMBL29002963 | 0.52 | MEN1 (0.33) | — | |
| Water SCHEMBL7917398 | 0.52 | MEN1 (0.67) | — | |
| SCHEMBL29247934 | 0.47 | MEN1 (0.75) | — | |
| SCHEMBL27527123 | 0.47 | MEN1 (0.75) | — | |
| SCHEMBL82597 | 0.47 | MEN1 (0.75) | — | |
| SCHEMBL5828494 | 0.47 | MEN1 (0.75) | — | |
| SCHEMBL651428 | 0.47 | MEN1 (0.75) | — | |
| SCHEMBL4365635 | 0.46 | MEN1 (0.33) | — | |
| Water SCHEMBL9747957 | 0.46 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6828125-B1 | DNA encoding fused di-alpha globins and use thereof | BAXTER BIOTECH TECHNOLOGY, S.A.R.L. (CH) | 2004-12-07 | — | — | US | disclosed |
| US-6274331-B1 | USING RECOMBINANT DNA VECTORS WHICH ENCODE DI-ALPHA OR DI-BETA GLOBIN-LIKE POLYPEPTIDE HAVING LINKER, TRANSFORMING CELLS, SCREENING FOR PRODUCTION BY DETERMINING RESPONSE TO CARBON MONOXIDE, DETERMINING AMINO ACID SEQUENCE OF LINKER | SOMATOGEN, INC. | 2001-08-14 | — | — | US | disclosed |
| US-6184356-B1 | GLOBIN PROTEIN; FOR AMPLIFYING OXYGEN CARRYING CAPACITY OF A BLOOD SUBSTITUTE | BAXTER BIOTECH TECHNOLOGY SARL (CH) | 2001-02-06 | — | — | US | disclosed |
| US-5844089-A | Genetically fused globin-like polypeptides having hemoglobin-like activity | SOMATOGEN, INC. (US) | 1998-12-01 | — | — | US | disclosed |
| US-5844088-A | Hemoglobin-like protein comprising genetically fused globin-like polypeptides | SOMATOGEN, INC. (US) | 1998-12-01 | — | — | US | disclosed |
| US-5801019-A | DNA encoding fused alpha-beta globin pseuodimer and production of pseudotetrameric hemoglobin | SOMATOGEN, INC. (US) | 1998-09-01 | — | — | US | disclosed |
| US-5798227-A | EXPRESSING THE GLOBULINS IN THE SAME CELL SUCH THAT ALPHA AND BETA GLOBULIN-LIKE POLYPEPTIDES ARE ASSEMBLED AND COMBINED WITH HEME TO PRODUCE A HEMOGLOBIN-LIKE PROTEIN | SOMATOGEN, INC. (US) | 1998-08-25 | — | — | US | disclosed |
| EP-0857489-A2 | Production and use of multimeric hemoglobins | SOMATOGEN, INC. (US) | 1998-08-12 | — | — | EP | disclosed |
| EP-0611376-B1 | PRODUCTION AND USE OF MULTIMERIC HEMOGLOBINS | SOMATOGEN INC (US) | 1998-06-17 | — | — | EP | disclosed |
| US-5744329-A | DNA encoding fused di-beta globins and production of pseudotetrameric hemoglobin | SOMATOGEN, INC. (US) | 1998-04-28 | — | — | US | disclosed |
| US-5739011-A | NON-NATURALLY OCCURRING DNA MOLECULE COMPRISING A DNA SEQUENCE ENCODING A PSEUDODIMERIC GLOBIN-LIKE POLYPEPTIDE HAVING TWO HOMOLOGOUS GLOBIN-LIKE DOMAINS, ONE OF WHICH IS MUTATED TO PROVIDE AN ASYMMETRIC CROSSLINKABLE CYSTEINE RESIDUE | SOMATOGEN, INC. (US) | 1998-04-14 | — | — | US | disclosed |
| US-5599907-A | ARTIFICIAL CYSTEINES SELECTIVELY INTRODUCED TO CONTROL POLYMERIZATION; SUPPLEMENTING THE OXYGEN CARRYING CAPACITY OF BLOOD | SOMATOGEN, INC. (US) | 1997-02-04 | — | — | US | disclosed |
| US-5545727-A | DNA MOLECULE COMPRISING DNA SEQUENCE CODING FOR PSEUDODIMERIC DI-ALPHA-GLOBIN-LIKE POLYPEPTIDE CAPABLE OF ASSOCIATING WITH BETA-GLOBIN AND INCORPORATING HEME TO FORM PSEUDOTETRAMERIC HEMOGLOBIN-LIKE PROTEIN WHICH REVERSIBLY BINDS OXYGEN | SOMATOGEN, INC. (US) | 1996-08-13 | — | — | US | disclosed |
| WO-1993009143-A1 | PRODUCTION AND USE OF MULTIMERIC HEMOGLOBINS | SOMATOGEN, INC. (US) | 1993-05-13 | — | — | WO | disclosed |